Options strategy index

Options Strategies

Compare economic results and evidence quality directly. ROI alone does not approve a strategy; each row explains whether the blocker is performance, insufficient evidence, or unavailable data.

Option strategy versions51
Experimental paper candidates6
Historically validated0
Experimental paper-observation candidates 6 candidates
These strategies had positive base- and adverse-cost results, but not enough historical trades for validation. Prospective observation gathers new evidence; it is not live approval. View observation queue
VersionAssetStructure testedROIWin rateRisk Paper-observation status and reasonActions
T1-LC1 SPYSPDR S&P 500 ETF Trust monthly decisions +1.90%Adverse costs +1.87% +50.00%6 completed trades 0.52Max drawdown −3.02% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T1-PV1 SPYSPDR S&P 500 ETF Trust monthly decisions +0.26%Adverse costs +0.17% +50.00%6 completed trades 0.07Max drawdown −3.01% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T2-BWB1W SPYSPDR S&P 500 ETF Trust weekly / 10 sessions decisions +0.93%Adverse costs +0.34% +50.00%6 completed trades 0.46Max drawdown −1.30% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T2-CC1W SPYSPDR S&P 500 ETF Trust weekly / 10 sessions decisions +2.75%Adverse costs +2.68% +50.00%8 completed trades 0.46Max drawdown −3.18% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T2-CSP1W SPYSPDR S&P 500 ETF Trust weekly / 10 sessions decisions +0.62%Adverse costs +0.55% +62.50%8 completed trades 0.34Max drawdown −0.84% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T2-LC1W SPYSPDR S&P 500 ETF Trust weekly / 10 sessions decisions +1.01%Adverse costs +0.96% +70.00%10 completed trades 0.31Max drawdown −2.69% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.

Single-stock options · proposed trade reviews

User-submitted option ideas appear here for transparent economics and risk review. They are not immutable strategies, historical validation results, or order instructions.

NBIS · Nebius Group N.V.1 proposed trade review
ContractMarket snapshotExpiration economicsPaper-risk reviewActions
NBIS $170 put Expires 12-18-26 $18.70 delayed ask ceiling Seller-side bid and reliable current stock quote unavailable $1,870 max profit $151.30 expiration break-even at the reference credit Not authorized Failed the 09/14 v1.1 cap; v1.3 enables no single-stock collateral class View analysis
SPY · SPDR S&P 500 ETF Trust 23 option strategy versions6 paper candidates
VersionStructure testedROIWin rateRisk Paper-observation status and reasonActions
v0.1 Regime-routed structures, and +0.14%3¢ slippage −0.23% 33.33%3 completed trades 0.33Max drawdown −0.20% Historical evidence unfavorableAdverse-cost ROI was negative and the holdout materially lagged SPY; this is not merely a volume problem.
T1-LC1 monthly decisions +1.90%Adverse costs +1.87% +50.00%6 completed trades 0.52Max drawdown −3.02% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T1-CV1 monthly decisions +0.53%Adverse costs +0.50% +50.00%2 completed trades 0.31Max drawdown −0.80% Too little evidenceOnly 2 completed historical trades—too little evidence to call the result promising.
T1-PV1 monthly decisions +0.26%Adverse costs +0.17% +50.00%6 completed trades 0.07Max drawdown −3.01% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T1-CSP1 monthly decisions −0.16%Adverse costs −0.19% +50.00%4 completed trades -0.05Max drawdown −1.30% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-CC1 monthly decisions −7.59%Adverse costs −7.62% +25.00%4 completed trades -0.81Max drawdown −9.03% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-PCV1 monthly decisions −1.02%Adverse costs −1.03% +50.00%2 completed trades -0.65Max drawdown −1.34% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-IC1 monthly decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-IF1 monthly decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-LS1 monthly decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-CAL1 monthly decisions −0.03%Adverse costs −0.10% +50.00%2 completed trades -0.03Max drawdown −0.53% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-DIA1 monthly decisions −1.24%Adverse costs −1.26% +50.00%2 completed trades -1.14Max drawdown −1.42% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T1-BWB1 monthly decisions −0.42%Adverse costs −0.47% +0.00%1 completed trades -0.23Max drawdown −0.97% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T2-LC1W weekly / 10 sessions decisions +1.01%Adverse costs +0.96% +70.00%10 completed trades 0.31Max drawdown −2.69% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T2-CV1W weekly / 10 sessions decisions +0.07%Adverse costs −0.15% +63.64%11 completed trades 0.03Max drawdown −2.77% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T2-PV1W weekly / 10 sessions decisions −1.02%Adverse costs −1.19% +45.45%11 completed trades -0.24Max drawdown −4.96% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T2-CSP1W weekly / 10 sessions decisions +0.62%Adverse costs +0.55% +62.50%8 completed trades 0.34Max drawdown −0.84% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T2-CC1W weekly / 10 sessions decisions +2.75%Adverse costs +2.68% +50.00%8 completed trades 0.46Max drawdown −3.18% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
T2-PCV1W weekly / 10 sessions decisions −0.08%Adverse costs −0.28% +50.00%6 completed trades -0.10Max drawdown −0.47% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T2-IC1W weekly / 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T2-IF1W weekly / 10 sessions decisions −1.06%Adverse costs −1.57% +33.33%3 completed trades -0.69Max drawdown −1.59% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T2-LS1W weekly / 10 sessions decisions +0.32%Adverse costs +0.31% +100.00%1 completed trades 0.52Max drawdown −0.14% Too little evidenceOnly 1 completed historical trade—too little evidence to call the result promising.
T2-BWB1W weekly / 10 sessions decisions +0.93%Adverse costs +0.34% +50.00%6 completed trades 0.46Max drawdown −1.30% Paper observation candidatePositive ROI, adverse-cost ROI, and Sharpe; sample size was the only failed historical gate.
IWM · iShares Russell 2000 ETF 5 option strategy versions
VersionStructure testedROIWin rateRisk Paper-observation status and reasonActions
T5-IWM-PCS3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-IWM-IC3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-IWM-CAL3 monthly / up to 15 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-IWM-LS3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-IWM-BF3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
MU · Micron Technology, Inc. 6 option strategy versions
VersionStructure testedROIWin rateRisk Paper-observation status and reasonActions
T6-MU-MOC4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 4 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-MU-MDS4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 4 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-MU-PPS4 weekly / up to 5 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 2 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-MU-BDS4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 3 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-MU-VES4 weekly / up to 5 sessions decisions −0.05%Adverse costs −0.26% +40.00%5 completed trades -0.03Max drawdown −0.58% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
T6-MU-BWB4 weekly / up to 7 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 4 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
NVDA · NVIDIA Corporation 6 option strategy versions
VersionStructure testedROIWin rateRisk Paper-observation status and reasonActions
T6-NVDA-MOC4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Risk budget incompatibleAll 5 planned validation trades exceeded the frozen 0.75% one-complex maximum-loss budget; no position could be opened safely.
T6-NVDA-MDS4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Risk budget incompatibleAll 5 planned validation trades exceeded the frozen 0.75% one-complex maximum-loss budget; no position could be opened safely.
T6-NVDA-PPS4 weekly / up to 5 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 4 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-NVDA-BDS4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Risk budget incompatibleAll 5 planned validation trades exceeded the frozen 0.75% one-complex maximum-loss budget; no position could be opened safely.
T6-NVDA-VES4 weekly / up to 5 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 4 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-NVDA-BWB4 weekly / up to 7 sessions decisions −0.22%Adverse costs −0.30% +0.00%1 completed trades -0.78Max drawdown −0.22% Historical evidence unfavorableValidation ROI, adverse-cost ROI, or Sharpe was not positive; this is a performance blocker, not a volume blocker.
QQQ · Invesco QQQ Trust 5 option strategy versions
VersionStructure testedROIWin rateRisk Paper-observation status and reasonActions
T5-QQQ-PCS3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-QQQ-IC3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-QQQ-CAL3 monthly / up to 15 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-QQQ-LS3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
T5-QQQ-BF3 monthly / up to 20 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableRequired liquid near/far option pairs were usually unavailable, so ROI and win rate could not be measured.
TSLA · Tesla, Inc. 6 option strategy versions
VersionStructure testedROIWin rateRisk Paper-observation status and reasonActions
T6-TSLA-MOC4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 0 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-TSLA-MDS4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 0 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-TSLA-PPS4 weekly / up to 5 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 3 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-TSLA-BDS4 weekly / up to 10 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 0 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.
T6-TSLA-VES4 weekly / up to 5 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Risk budget incompatibleAll 4 planned validation trades exceeded the frozen 0.75% one-complex maximum-loss budget; no position could be opened safely.
T6-TSLA-BWB4 weekly / up to 7 sessions decisions Not measuredAdverse costs Not measured Not measured0 completed trades Not measuredMax drawdown Not measured Not measurableOnly 0 validation signals were possible before option liquidity and overlap; the frozen historical minimum was 25 and the experimental-observation floor was 5.